Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.1 SEK | +3.06% | +4.99% | -9.98% |
06/02 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
06/02 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 53.06M 4.43B | Sales 2025 * | 620M 56.76M 4.74B | Capitalization | 381M 34.83M 2.91B |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.56M 214M | Net income 2025 * | 41M 3.75M 313M | EV / Sales 2024 * | 0.79 x |
Net Debt 2024 * | 77.93M 7.13M 595M | Net Debt 2025 * | 75.63M 6.92M 577M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
9.09
x | Employees | 228 |
Yield 2024 * |
2.09% | Yield 2025 * |
3.47% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | +1.43% | ||
1 week | +4.99% | ||
Current month | +1.71% | ||
1 month | +2.64% | ||
3 months | -12.02% | ||
6 months | +9.78% | ||
Current year | -9.98% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | 01/01 |
Aishat Bislieva
HRO | Human Resources Officer | - | 01/22/01 |
Fredrik Ekdahl
PRN | Corporate Officer/Principal | - | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 01/21/01 | |
Chairman | 72 | 01/21/01 | |
Director/Board Member | 57 | 01/14/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 10.1 | +3.06% | 63 477 |
26/24/26 | 9.8 | +4.03% | 39,281 |
25/24/25 | 9.42 | -1.46% | 19,433 |
24/24/24 | 9.56 | -1.44% | 1,521 |
23/24/23 | 9.7 | +0.83% | 2,928 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 08:54 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 34.71M | |
+8.96% | 219B | |
+7.38% | 183B | |
+11.19% | 133B | |
+25.21% | 108B | |
+0.57% | 63.06B | |
+12.60% | 52.02B | |
-0.62% | 48.2B | |
+0.03% | 40.37B | |
+13.36% | 39.35B |
- Stock Market
- Equities
- BOUL Stock